News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
898,168 Results
Type
Article (89677)
Company Profile (639)
Press Release (807828)
Multimedia
Podcasts (283)
Webinars (44)
Section
Business (267513)
Career Advice (4176)
Deals (40163)
Drug Delivery (246)
Drug Development (92152)
Employer Resources (212)
FDA (18737)
Job Trends (17563)
News (399634)
Policy (40038)
Tag
2025 Best Places to Work (25)
2026 Best Places to Work (39)
2027 BioCapital Standard (5)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (13)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Standard (7)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 NextGen (10)
2027 Pharm Country Digital (4)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
40 Under 40 (4)
Academia (3112)
Academic (2)
Accelerated approval (76)
ADA (54)
Adcomms (44)
Allergies (237)
Alliances (57000)
ALS (293)
Alzheimer's disease (2152)
Antibody-drug conjugate (ADC) (778)
Approvals (19335)
Artificial intelligence (1147)
ASCO (350)
Autoimmune disease (537)
Automation (84)
Bankruptcy (414)
Belgium (45)
Best Places to Work (12636)
BIO (84)
Biologics (120)
BIOSECURE Act (23)
Biosimilars (308)
BioSpace Insights (271)
Biotechnology (340)
Bispecific (60)
Bladder cancer (253)
Brain cancer (104)
Breast cancer (981)
Cancer (8067)
Cardiovascular disease (684)
Career advice (3638)
Career pathing (65)
CAR-T (465)
CDC (82)
CDMO (236)
Celiac Disease (7)
Cell-line development (2)
Cell therapy (1280)
Cervical cancer (67)
Clinical research (81245)
Collaboration (2895)
Commercialization (76)
Company closure (10)
Compensation (1937)
Complete response letters (128)
COVID-19 (3089)
CRISPR (155)
CRO (8)
C-suite (1713)
Cystic fibrosis (183)
Data (11176)
Decentralized trials (4)
Denatured (112)
Depression (230)
Dermatology (207)
Diabetes (855)
Diagnostics (7948)
Digital health (86)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (566)
Drug pricing (255)
Drug shortages (41)
Duchenne muscular dystrophy (388)
Earnings (104811)
Editorial (85)
Employer branding (27)
Employer resources (184)
ESMO (441)
Events (141993)
Executive appointments (1385)
Eye disease (28)
FDA (23869)
Fibrodysplasia Ossificans Progressiva (17)
Fragile X (6)
Friedreich's ataxia (29)
Frontotemporal dementia (43)
Funding (2383)
Gene editing (323)
Generative AI (116)
Gene therapy (990)
GLP-1 (1416)
Government (5635)
Grass and pollen (8)
Guidances (446)
Healthcare (21523)
Hematology (236)
HIV (128)
Huntington's disease (93)
Idiopathic pulmonary fibrosis (16)
IgA nephropathy (155)
Immunology and inflammation (432)
Immuno-oncology (166)
Indications (298)
Infectious disease (3551)
Inflammatory bowel disease (285)
Inflation Reduction Act (17)
Influenza (168)
Intellectual property (390)
Interviews (830)
IPO (18072)
IRA (61)
Job creations (5211)
Job search strategy (2882)
JPM (73)
Kidney cancer (32)
Kidney disease (182)
Labor market (152)
Layoffs (733)
Leadership (70)
Legal (10180)
Licensing (131)
Liver cancer (121)
Longevity (58)
Lung cancer (1111)
Lung diease (27)
Lymphoma (566)
Machine learning (78)
Management (72)
Manufacturing (1660)
Marketing (41)
MASH (260)
Medical affairs (5)
Medical device (15486)
Medtech (15823)
Mergers & acquisitions (23653)
Metabolic disorders (2176)
Middle East (2)
mRNA (345)
Multiple sclerosis (262)
Multispecific (6)
NASH (24)
Netherlands (41)
Neurodegenerative disease (637)
Neuropsychiatric disorders (155)
Neuroscience (4371)
Neurotech (4)
NextGen: Class of 2026 (7718)
Non-profit (5176)
Now hiring (101)
Obesity (1028)
Opinion (410)
Ovarian cancer (301)
Pain (352)
Pancreatic cancer (459)
Parkinson's disease (496)
Partnered (53)
Patents (815)
Patient advocacy (8)
Patient recruitment (988)
Patient selection (117)
Peanut (81)
People (69165)
Peptides (45)
Pharmaceutical (83)
Pharmacy benefit managers (43)
Phase 1 (25055)
Phase 2 (35292)
Phase 3 (26601)
Pipeline (14681)
Policy (435)
Postmarket research (3561)
Preclinical (11210)
Press Release (74)
Prostate cancer (414)
Psychedelics (104)
Radioligand (3)
Radiopharmaceuticals (449)
Rare diseases (1617)
Real estate (7479)
Recruiting (84)
Regenerative medicine (38)
Regulatory (31907)
Reports (104)
Research institute (2823)
Resumes & cover letters (657)
Rett syndrome (60)
RNA editing (39)
RSV (107)
Saudi Arabia (1)
Schizophrenia (231)
Series A (410)
Series B (285)
Service/supplier (17)
Sickle cell disease (153)
Special edition (38)
Spinal muscular atrophy (201)
Sponsored (61)
Startups (4405)
State (2)
Stem cells (8)
Stomach cancer (24)
Substance use disorders (23)
Supply chain (173)
Switzerland (25)
Tariffs (108)
Tax incentives (2)
The Weekly (168)
Vaccines (1448)
Venture capital (186)
Weight loss (683)
Wet AMD (7)
Women's health (190)
Women in leadership (2)
Worklife (28)
Date
Today (235)
Last 7 days (970)
Last 30 days (4039)
Last 365 days (34019)
2026 (30797)
2025 (33214)
2024 (37866)
2023 (42564)
2022 (53927)
2021 (58720)
2020 (57662)
2019 (51334)
2018 (39119)
2017 (37186)
2016 (38329)
2015 (44431)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1310)
Alabama (118)
Alaska (7)
Arizona (493)
Arkansas (17)
Asia (53211)
Australia (9370)
California (17377)
Canada (4780)
China (2070)
Colorado (772)
Connecticut (776)
Delaware (548)
Europe (122871)
Florida (2632)
Georgia (567)
Hawaii (5)
Idaho (70)
Illinois (1502)
India (156)
Indiana (786)
Iowa (37)
Japan (783)
Kansas (159)
Kentucky (69)
Louisiana (73)
Maine (99)
Maryland (2049)
Massachusetts (12577)
Michigan (476)
Minnesota (954)
Mississippi (8)
Missouri (190)
Montana (38)
Nebraska (31)
Nevada (206)
New Hampshire (94)
New Jersey (4601)
New Mexico (38)
New York (4527)
North Carolina (2250)
North Dakota (14)
Northern California (8876)
Ohio (542)
Oklahoma (32)
Oregon (55)
Pennsylvania (3325)
Puerto Rico (38)
Rhode Island (66)
South America (1674)
South Carolina (105)
South Dakota (2)
Southern California (6926)
Tennessee (287)
Texas (2892)
United States (61590)
Utah (528)
Vermont (2)
Virginia (436)
Washington D.C. (89)
Washington State (1387)
West Virginia (4)
Wisconsin (200)
Wyoming (6)
There are 898,168 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Eikon Therapeutics Announces Clearance to Proceed with First-in-Human Phase 1/2 Study for Novel Androgen Receptor Antagonist EIK1006 in Advanced Metastatic Prostate Cancer
November 17, 2026
·
5 min read
Press Releases
Cognition Therapeutics Announces CTAD Poster Highlighting Screening Efficiencies with p-Tau217 in the Ongoing Phase 2 START Study
November 17, 2026
·
8 min read
Press Releases
Greenwich LifeSciences Announces Acceptance of Abstracts at SABCS 2026
November 17, 2026
·
3 min read
Press Releases
Hyalex Orthopaedics Announces First Commercial Case with the Slalom MTP Implant for Hallux Rigidus
November 17, 2026
·
2 min read
Earnings
Genetix’s genetic medicines are officially profitable, with $327M in sales YTD
It’s been a long road to financial stability for Genetix Biotherapeutics, the rebranded name of bluebird bio following its February 2025 sale to two private equity firms, but on Monday the biotech estimated full year 2026 sales will reach $500 million.
November 17, 2026
·
3 min read
·
Annalee Armstrong
Funding
Marrow Therapeutics debuts with $173M to tackle blood disorders in vivo
Marrow Therapeutics aims to address safety and accessibility obstacles in genetic medicines by delivering therapies straight to bone marrow cells.
November 17, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Nuclera and University of Cambridge Researchers Demonstrate Rapid Structural Analysis of Challenging Drug Target
November 17, 2026
·
3 min read
Press Releases
Enterprise Therapeutics Granted EMA Orphan Medicinal Product Designation for Novel Cystic Fibrosis Therapy, ETD001
November 17, 2026
·
2 min read
Press Releases
Ascletis Submits IND Application to the U.S. FDA for ASC36_37o FDC, a Potentially First-in-Class Once-Weekly Oral Quadruple Peptide Agonist Targeting Amylin Receptor, GLP-1R, GIPR and GCGR, for the Treatment of Obesity
November 17, 2026
·
4 min read
Press Releases
TRYNGOLZA™ (olezarsen) approved in the EU for severe hypertriglyceridemia (sHTG)
November 17, 2026
·
8 min read
1 of 89,817
Next